"Mobile Stroke Unit"-Concept for Delivery of Specialized Acute Stroke Care

Status Completed

Clinical Trial Summary

Treatment of acute stroke must be fast. The aim of this trial is to show feasibility, safety and clinical benefit of a strategy of diagnosis and treatment directly at the emergency site for hyperacute treatment and transfer to the most appropriate target hospital. The effects on reduction delays until different stroke treatments will be assessed. First estimations of cost-effectiveness will also be performed.

Clinical Trial Description

Stroke is a medical emergency for which "time-is-brain". Indeed, a huge body of animal experimental and clinical evidence exists that demonstrates that reducing the time to thrombolytic therapy is the most important variable in prevention of the disability. However, most stroke patients arrive to hospital too late for any type of acute stroke treatment: Only an estimated 19-60% of stroke patients present within 3 hours after symptom onset. Today, for stroke patients 3 different treatment options exist.

1. Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is an effective treatment for many acute stroke patients as evidenced by several large randomized trials.

2. More recently, mechanical clot removal via catheters has been developed. There is currently increasing evidence that in obstruction of large brain vessels such endovascular treatment is superior to systemic thrombolysis in regard to recanalization rates and outcome.

3. Patients with intracranial hemorrhage can profit if transferred to hospitals with neurosurgical treatment options such as ventricular drainage or hematoma removal.

However, each of these treatment are highly time sensitive and due the availability of endovascular and neurosurgical treatment options only in very few highly specialized neurovascular centres decision in which institution the patient should be transported is of high medical and financial relevance. The aim of this trial is to show feasibility, safety and clinical benefit of a strategy of diagnosis and treatment directly at the emergency site and its role in decision regarding transfer to appropriate target institution, thus potentially allowing reduction of time until treatment and delays until specialized treatment also in remote regions. First estimations of cost-effectiveness will also be performed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02465346
Study type	Interventional
Source	University Hospital, Saarland
Contact
Status	Completed
Phase	N/A
Start date	June 2015
Completion date	February 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03281590` - Stroke and Cerebrovascular Diseases Registry
Enrolling by invitation	`NCT06074081` - Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.	N/A
Terminated	`NCT04039178` - Efficacy of EMF BCI Based Device on Acute Stroke	N/A
Completed	`NCT04521634` - Glycaemic Variability in Acute Stroke
Completed	`NCT03477188` - The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.	N/A
Recruiting	`NCT05065216` - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)	Phase 2/Phase 3
Recruiting	`NCT02677415` - Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment	N/A
Recruiting	`NCT01541163` - Heart and Ischemic STrOke Relationship studY	N/A
Completed	`NCT01210729` - Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke	Phase 2
Recruiting	`NCT00785343` - Study of Robot-assisted Arm Therapy for Acute Stroke Patients	Phase 1
Completed	`NCT04779710` - How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
Active, not recruiting	`NCT03635749` - Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis	Phase 3
Recruiting	`NCT06149754` - BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
Recruiting	`NCT04491695` - Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke	Phase 2/Phase 3
Recruiting	`NCT04283760` - Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
Recruiting	`NCT05454397` - A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
Completed	`NCT04488692` - Early Functional Training in Acute Stroke Inpatient Ward	N/A
Recruiting	`NCT04214522` - Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
Not yet recruiting	`NCT04157231` - Essential Acute Stroke Care in Low Resource Settings: a Pilot studY	N/A
Recruiting	`NCT05469438` - IMAS Optimization and Applicability in an Acute Stroke Setting.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

"Mobile Stroke Unit"-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms